Acesion Pharma Funding: $51M Raised, Series B (2023)

Acesion Pharma is based in Copenhagen, Denmark. It has raised $51M in total funding. Latest round: Series B.

Acesion Pharma funding overview

Acesion Pharma is based in Copenhagen, Denmark. Acesion Pharma has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Acesion Pharma runs through 2023; nothing later has been disclosed. Investors on record include Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings. 4 distinct backers are named across the disclosed rounds.

Acesion Pharma at a glance

Total raised
$51M
Latest round
Series B
Latest round date
September 2023
Headquarters
Copenhagen, Denmark
Notable investors
Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings

Frequently asked about Acesion Pharma funding

How much has Acesion Pharma raised?
Acesion Pharma has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Acesion Pharma?
Canaan, Alpha Wave Global, Global BioAccess Fund, Novo Holdings are named among the investors backing Acesion Pharma.
What was the latest Acesion Pharma funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Acesion Pharma based?
Acesion Pharma is based in Copenhagen, Denmark.
When did Acesion Pharma last raise?
The last disclosed Acesion Pharma round closed in September 2023 at Series B.

Round data for Acesion Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Copenhagen and backer lists below.

Companies related to Acesion Pharma (36)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026